Montag A & Associates Inc. Buys 2,209 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Montag A & Associates Inc. raised its stake in Intuitive Surgical by 16.4%, buying 2,209 shares to hold 15,650 shares worth about $8.86 million per its latest 13F filing.
• Intuitive Surgical beat expectations in its most recent quarter, reporting $2.50 EPS (vs. $2.08 consensus) and $2.77 billion in revenue, up 23% year-over-year.
• Analyst and ownership backdrop: the stock has a "Moderate Buy" consensus (average price target $581.91: 18 Buys, 7 Holds, 1 Sell) and about 83.6% of shares are held by institutional investors.

Montag A & Associates Inc. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,650 shares of the medical equipment provider's stock after purchasing an additional 2,209 shares during the period. Montag A & Associates Inc.'s holdings in Intuitive Surgical were worth $8,863,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of ISRG. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. grew its position in Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $27,000. Olistico Wealth LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $28,000. Finally, Caitlin John LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $457.78 on Friday. The stock's fifty day moving average price is $474.86 and its two-hundred day moving average price is $516.55. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88. The company has a market cap of $162.13 billion, a price-to-earnings ratio of 55.49, a P/E/G ratio of 3.67 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the business earned $1.81 EPS. The business's revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of research analyst reports. Barclays set a $651.00 price target on Intuitive Surgical and gave the stock an "overweight" rating in a research report on Thursday, April 23rd. Robert W. Baird increased their price target on Intuitive Surgical from $575.00 to $610.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 22nd. UBS Group decreased their price target on Intuitive Surgical from $570.00 to $550.00 and set a "neutral" rating on the stock in a research report on Tuesday, March 17th. Raymond James Financial decreased their price target on Intuitive Surgical from $615.00 to $577.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 22nd. Finally, JPMorgan Chase & Co. decreased their price target on Intuitive Surgical from $625.00 to $550.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $581.91.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the company's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president owned 409 shares of the company's stock, valued at approximately $202,438.64. This represents a 50.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Patricia L. Wadors sold 220 shares of the company's stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 5,906 shares of company stock worth $2,907,726. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.